Nektar Therapeutics
NKTR
#6198
Rank
NZ$1.51 B
Marketcap
NZ$74.43
Share price
-7.17%
Change (1 day)
211.59%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$13.62

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$13.64. In 2024 the company made an earnings per share (EPS) of NZ-$15.17 an increase over its 2023 EPS that were of NZ-$37.49.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$13.62-10.2%
2024NZ-$15.17-59.54%
2023NZ-$37.49-25.89%
2022NZ-$50.58-31.12%
2021NZ-$73.4414.86%
2020NZ-$63.94-1.19%
2019NZ-$64.71-163.96%
2018NZ$101.17-725.4%
2017NZ-$16.18-42.73%
2016NZ-$28.2483.33%
2015NZ-$15.4139.53%
2014NZ-$11.04-69.29%
2013NZ-$35.95-6.67%
2012NZ-$38.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$22.30-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.94-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.00-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
NZ$0.01712-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.20-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
NZ-$1.13-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.54-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
NZ$17.87-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA